Results 81 to 90 of about 16,159 (251)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Continuous subcutaneous apomorphine infusion (CSAI) is effective in Parkinson's disease but has not been evaluated in multiple system atrophy (MSA). Objective To assess the 6‐month efficacy and tolerability of CSAI in MSA patients. Methods French multicenter retrospective registry‐based analysis of CSAI use in MSA.
Simon Lamy +16 more
wiley +1 more source
Brain CirculationBelly dancer’s dyskinesia (BDD) is characterized by involuntary abdominal wall movements that are rhythmic, repetitive, and dyskinetic. The present study aims to review BDD’s etiology, pathophysiology, and management.
Jamir Pitton Rissardo +4 more
doaj +1 more source
Socio‐Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Socio‐occupational functioning in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN‐DBS) is not fully captured by standard motor and quality‐of‐life scales. Objectives To characterize patient‐reported socio‐occupational functioning after STN‐DBS and explore associated clinical and ...
Gabriele Imbalzano +7 more
wiley +1 more source
Primary ciliary dyskinesia: a biopsychosocial approach [PDF]
, 2016 Background: Primary ciliary dyskinesia (PCD) is a rare heterogeneous genetic disorder associated with abnormal ciliary structure and function and characterised by progressive sinopulmonary disease. There is no ‘gold standard’ for diagnosing PCD.
Behan, Laura
core +1 more source
Frontiers in Neuroscience, 2019 Mutations in the PARKIN gene cause early-onset Parkinson’s disease (PD). Despite the high proportion of still missing phenotyping data in the literature devoted to early-onset PD, studies suggest that, as compared with late-onset PD, PARKIN patients show
Jenny Sassone +4 more
doaj +1 more source
, 2019 Tardive dyskinesia is now widely recognised as a neurological disorder associated with the administration of antipsychotic drugs. Prevalence is higher among the elderly.
Blowers, A. J., Blowers, Anthony John
core
MetabolitesParkinson’s disease (PD), a widely recognized neurodegenerative disorder, is characterized by a spectrum of symptoms including motor fluctuations and dyskinesia.
Jan Milanowski +4 more
doaj +1 more source
, 2018 Vibhash D Sharma, Kelly E Lyons, Rajesh Pahwa Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA Abstract: Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on ...
Pahwa R, Lyons KE, Sharma VD
core
Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels +3 more
wiley +1 more source
Probable respiratory dyskinesia in an elderly patient after sudden stoppage of antipsychotics
Journal of Geriatric Mental Health, 2016 Antipsychotic drugs are widely used in the management of schizophrenia in the elderly. Extrapyramidal reactions to these drugs and tardive dyskinesia are a dreaded side effect of these drugs that may be seen in the elderly. We present herewith, a case of
Vikram Vaidya +2 more
doaj +1 more source